Jeff Atlas, PA-C, manages peptide protocols and performs injections at Formation
Canadian Regulatory Context BPC-157 has not been approved for human medical use by Health Canada or any other major regulatory body, including the U.S
Further research is warranted to elucidate its optimal usage in clinical practice
Insert the needle into the vial, push the air in (to prevent a vacuum), and draw your prescribed dose into the syringe
Withdrawal Considerations : Studies examining discontinuation of aod 9604 peptide therapy generally show minimal withdrawal effects, suggesting low potential for dependency-related issues
Documentation and record keeping Treatment log: Date started each peptide, dosing schedule, any modifications, side effects or reactions, concurrent treatments or supplements, costs for insurance or tax purposes